Medical Journals

Chronic Hepcidin Induction Causes Hyposideremia and Alters the Pattern of Cellular Iron Accumulation in Hemochromatotic Mice.

Authors:
  • Viatte Lydie
  • Nicolas Gaël
  • Lou Dan-Qing
  • Bennoun Myriam
  • Lesbordes-Brion Jeanne-Claire
  • Canonne-Hergaux François
  • Schönig Kai
  • Bujard Hermann
  • Kahn Axel
  • Andrews Nancy C
  • Vaulont Sophie

From: Institut Cochin, Faculté de Médecine Cochin Port Royal, 24, rue du Faubourg Saint Jacques 75014 Paris, France.

Blood

  • Publish Date: Apr 2006
  • ISSN: 0006-4971
  • Volume: 107
  • Issue: 7
  • Pages: 2952-8
  • Medium: Print
  • Language: English
  • Citation (JAMA): Viatte Lydie, Nicolas Gaël, Lou Dan-Qing, et al. Chronic Hepcidin Induction Causes Hyposideremia and Alters the Pattern of Cellular Iron Accumulation in Hemochromatotic Mice.. Blood Apr 2006;107:2952-8

Abstract

We report the generation of a tetracycline-regulated (Tet ON) transgenic mouse model for acute and chronic expression of the iron regulatory peptide hepcidin in the liver. We demonstrate that short-term and long-term tetracycline-dependent activation of hepcidin in adult mice leads to hypoferremia and iron-limited erythropoiesis, respectively. This clearly establishes the key role of hepcidin in regulating the extracellular iron concentration. We previously demonstrated that, when expressed early in fetal development, constitutive transgenic hepcidin expression prevented iron accumulation in an Hfe-/- mouse model of hemochromatosis. We now explore the effect of chronic hepcidin expression in adult Hfe-/- mice that have already developed liver iron overload. We demonstrate that induction of chronic hepcidin expression in 2-month-old Hfe-/- mice alters their pattern of cellular iron accumulation, leading to increased iron in tissue macrophages and duodenal cells but less iron in hepatocytes. These hepcidin-induced changes in the pattern of cellular iron accumulation are associated with decreased expression of the iron exporter ferroportin in macrophages but no detectable alteration of ferroportin expression in the hepatocytes. We speculate that this change in iron homeostasis could offer a therapeutic advantage by protecting against damage to parenchymal cells.

Mesh Headings (Keywords): Animals, Anti-Bacterial Agents, Antimicrobial Cationic Peptides, Disease Models, Animal, Doxycycline, Hemochromatosis, Histocompatibility Antigens Class I, Iron, Membrane Proteins, Mice, Mice, Knockout, Tetracycline


Check for Full Text / PubMed Unique Identifier (PMID): 16339398


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.